Adam Pope
| This email address is being protected from spambots. You need JavaScript enabled to view it.Manager of Public Relations
arpope@uab.edu | (205) 934-6986Leads external communications for units within the medical entities. Pope and his team proactively tell stories through external media outlets, featuring news about research, clinical happenings, patient stories and beyond at UAB. The team works reactively to connect appropriate experts with media on subject matter expertise.
Specific beats:
- Health System Administration
- Heersink School of Medicine
- Medical Facilities
- Medical Partnerships/Alliances
- School of Health Professions
- Minority Health & Health Equity Research Center
- Live HealthSmart Alabama
- Department of Pathology
- Department of Surgery
- Transplantation
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
A rare brain tumor caused facial paralysis for a local award-winning theater actress, but thanks to UAB doctors she is ready to get back on stage.
Hall’s research focuses on improving access to high-quality health care among vulnerable populations including low income individuals and people living with a disability or chronic health condition.
Iyer is UAB’s first recipient of the Beeson award.
In her role at the HIIE, Nugent collaborates daily with top leaders across UAB and Birmingham and has unprecedented insight into navigating research and entrepreneurship opportunities.
Alabama is one of 10 U.S. states with the highest rates of short sleep duration.
Kimberly Hendershot, M.D., assistant professor in the UAB Division of Acute Care Surgery, has been named an associate member in the new American College of Surgeons Academy of Master Surgeon Educators™.
A study conducted by UAB investigators has outlined that Black individuals with heart failure have a worse prognosis, even after achieving biomarker-based heart failure treatment targets.
There is a narrow window of opportunity for successfully treating major cardiovascular events, and patients risk serious consequences if they wait for symptoms to get worse before seeking medical attention.
In a new trial funded through UAB’s urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.